Nov. 12 at 12:22 PM
$TXMD
Some updates in timeline and by next Friday decision or judgement should be made.
The overall markets worldwide are in a much better condition than 9 months ago when Cosette /Mayne deal announced. The M & A in biotech/healthcare sector has shown much higher valuations given to Buyout targets that have big real revenues. Everything equal, Mayne MC is worth more today than Feb for sure, if not because of the M&A holdout.
IMO Cosette should still see the M&A deal as a positive good deal even not getting a discount from so the called hidden FDA Letter. No bad intentions from Mayne.
I do share the concern that Cosette still keeps its funding commitments ready for this buyout deal, especially further legal battles into 2026.
Hope coolheaded wisdom prevail in next week.
And I wish I had sold all in last EW deal 3 yrs ago. Following Rubric has been proven a very bad idea. Give me
$3
https://x.com/fabreres/status/1988562305374699760?s=46&t=0dxFfv8Iw4yOBhPO0oZagA
